Andrea Hagemann, MD, MSCI

Andrea Hagemann, MD, MSCI

Gynecologic Oncology, Surgeon

Primary Academic Title

Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine

Clinical Expertise

Hereditary cancer risk assessment and management

As a member of our ovarian, cervical and endometrial cancer specialist teams, Dr. Hagemann cares for patients diagnosed with these cancers through treatment and recovery.

Research Interest

The surgical and medical management of gynecologic malignancies, complex pelvic surgery and minimally invasive surgery (laparoscopy and the da Vinci Surgical System). Hereditary cancer risk assessment and weight management for precision cancer treatment and prevention. Research interests include the study of weight management interventions for endometrial cancer treatment and prevention, implementation of cascade genetic testing into oncology practices for hereditary cancer risk, and the equitable implementation of molecular profiling for endometrial cancer. Dr. Hagemann is the current PI of Project 3 of the Endometrial SPORE.

Education

  • 2004: MD, Washington University, St. Louis

Training

  • 2004 - 2008: Resident, obstetrics and gynecology, Washington University, St. Louis
  • 2008 - 2010: Fellow, gynecologic oncology, University of Pennsylvania, Philadelphia
  • 2015 - 2017: Mentored Training Program in Dissemination & Implementation Research in Cancer, Washington University School of Medicine, St. Louis, Missouri
  • 2018 - 2019: City of Hope Intensive Course in Genomic Cancer Risk Assessment, Duarte, California

Board Certification

  • 2016: American Board of Obstetrics and Gynecology, Gynecologic Oncology
  • 2012: American Board of Obstetrics and Gynecology, Gynecologic Oncology

Selected Research Publications

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
  • Schab A, Compadre A, Drexler R, [...] Hagemann AR, [...] Mullen MM
  • J Clin Invest 2025
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
  • Daly MB, Pal T, Maxwell KN, [...] Hagemann A, [...] Darlow SD
  • J Natl Compr Canc Netw 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.
  • Compadre AJ, van Biljon LN, Valentine MC, [...] Hagemann AR, [...] Mullen MM
  • Clin Cancer Res 2023

View All Publications

Contact Information

  • Washington University Medical Campus

    Gary C. Werths Building at Siteman Cancer Center
    4500 Forest Park Avenue
    Saint Louis, MO 63108

    Center for Advanced Medicine at Siteman Cancer Center
    4921 Parkview Place
    Saint Louis, MO 63110

    Parkview Tower
    1 Parkview Place
    Saint Louis, MO 63110

    S. Lee Kling Proton Therapy Center
    224 Euclid Ave.
    Saint Louis, MO 63110

    Siteman Kids at St. Louis Children’s Hospital
    1 Children's Place
    St. Louis, MO 63110

Phone Numbers

Request an appointment